VMS PHARMACY LIMITED - Filleted accounts

Registered number

04918136

VMS PHARMACY LIMITED

Filleted Accounts

31 March 2026

VMS PHARMACY LIMITED
Registered number:		04918136
Balance Sheet
as at 31 March 2026

Notes			2026			2025
£				£
Fixed assets
Intangible assets	3		207,671			207,671
Tangible assets	4		64,828			63,945
Investments	5		841,002			841,002
			1,113,501			1,112,618

Current assets
Stocks		52,029			50,259
Debtors	6	166,541			360,561
Cash at bank and in hand		423			1,357
		218,993			412,177

Creditors: amounts falling due within one year	7	(177,309)			(518,091)

Net current assets/(liabilities)			41,684			(105,914)

Total assets less current liabilities			1,155,185			1,006,704

Creditors: amounts falling due after more than one year	8		(597,647)			(555,897)

Provisions for liabilities			-			(505)


Net assets			557,538			450,302

Capital and reserves
Called up share capital			1,000			1,000
Revaluation reserve	9		25,543			-
Profit and loss account			530,995			449,302

Shareholders' funds			557,538			450,302

The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.



Anup Patel
Director
Approved by the board on 15 September 2026

VMS PHARMACY LIMITED
Notes to the Accounts
for the period from 1 February 2025 to 31 March 2026


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Intangible fixed assets
	Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.

	Tangible fixed assets
	Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

	Plant and machinery	20% RBM

	Investments
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

	Stocks
	Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Provisions
	Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Leased assets
	A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term.

	Pensions
	Contributions to defined contribution plans are expensed in the period to which they relate.


2	Employees			2026		2025
Number					Number

	Average number of persons employed by the company			15		13


3	Intangible fixed assets					£
	Goodwill:

	Cost
	At 1 February 2025					207,671
	At 31 March 2026					207,671

	Amortisation
	At 31 March 2026					-

	Net book value
	At 31 March 2026					207,671
	At 31 January 2025					207,671

	Goodwill is being written off in equal annual instalments over its estimated economic life of 5 years.


4	Tangible fixed assets
		Land and buildings		Plant and machinery etc		Total
£			£		£
	Cost
	At 1 February 2025	60,334		67,126		127,460
	Additions	-		1,028		1,028
	At 31 March 2026	60,334		68,154		128,488

	Depreciation
	At 1 February 2025	-		63,515		63,515
	Charge for the period	-		145		145
	At 31 March 2026	-		63,660		63,660

	Net book value
	At 31 March 2026	60,334		4,494		64,828
	At 31 January 2025	60,334		3,611		63,945


5	Investments
Investments in
subsidiary
undertakings
£
	Cost
	At 1 February 2025					841,002

	At 31 March 2026					841,002





6	Debtors			2026		2025
£					£

	Trade debtors			98,419		61,285
	Other debtors			68,122		299,276
				166,541		360,561


7	Creditors: amounts falling due within one year			2026		2025
£					£

	Bank loans and overdrafts			39,294		123,065
	Trade creditors			131,824		140,596
	Taxation and social security costs			5,753		2,104
	Other creditors			438		252,326
				177,309		518,091


8	Creditors: amounts falling due after one year			2026		2025
£					£

	Bank loans			597,647		555,897


9	Revaluation reserve			2026		2025
£					£

	Gain on revaluation of land and buildings			25,543		-

	At 31 March 2026			25,543		-


10	Other information

	VMS PHARMACY LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
	Elthorne Gate
	64 High Street
	Pinner
	England
	HA5 5QA